In several observational studies of breast cancer follow-up, the incidence of subsequent secondary acute myeloid leukemia was increased in patients with breast cancer, which may be related to the dose intensity of chemotherapy, the use of adjuvant radiotherapy, and the use of granulocyte colony-stimulating factor (GCSF)22. The gene discussed is CSF3; the disease is breast cancer.